Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk

Randomized cardiovascular trials aimed to reduce the excessive residual risk in high‐risk patients through a more aggressive low‐density lipoprotein‐cholesterol control or targeting triglycerides or high‐density lipoprotein‐cholesterol levels have shown a null or, at best, limited incremental benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Werba, José P., Vigo, Lorenzo M., Veglia, Fabrizio, Marenzi, Giancarlo, Tremoli, Elena, Baldassarre, Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849695/
https://www.ncbi.nlm.nih.gov/pubmed/30916778
http://dx.doi.org/10.1002/cpt.1436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849695/
https://www.ncbi.nlm.nih.gov/pubmed/30916778
http://dx.doi.org/10.1002/cpt.1436

Ejemplares similares